rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Gary S. Stetz

Interim CEO

Company insider

Files Form 4 as: Interim CEO, Hepion Pharmaceuticals; Director, Canton Strategic Holdings; Director, BCB Bancorp, Inc. (NJ).

In numbers

Trades disclosed
60
Buys
21
Sells
2
Bought
$600K
Sold
$688K
Companies
3
Companies where not an officer
2
First trade
18 May 2012
Last trade
19 Aug 2026
Last filed
21 Aug 2026

Companies traded

Where they are an officer
Hepion PharmaceuticalsDirector, Officer · Biotechnology · last 19 Aug 20262 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
CNTN Canton Strategic HoldingsDirector · Digital Asset Treasuries · last 26 May 20260 buys · 2 sells
BCBP BCB Bancorp, Inc. (NJ)Director · Regional banks · last 14 Mar 201819 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
201Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
19 Aug 2026filed 21 Aug 2026Hepion Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—1,345,500 at $0.00filing
19 Aug 2026filed 21 Aug 2026Hepion Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—1,345,500 at $0.00filing
3 Aug 2026filed 12 Aug 2026Hepion PharmaceuticalsBiotechnologySEC FORM 4 Bought$100K2,000,000 at $0.05filing
3 Aug 2026filed 12 Aug 2026Hepion Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code P—2,000,000 at $0.00filing
3 Aug 2026filed 12 Aug 2026Hepion Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code P—2,000,000 at $0.00filing
3 Aug 2026filed 12 Aug 2026Hepion PharmaceuticalsBiotechnologySEC FORM 4 Bought$100K2,000,000 at $0.05filing
26 May 2026filed 27 May 2026CNTN Canton Strategic HoldingsDigital Asset TreasuriesSEC FORM 4 Sold$43K12,500 at $3.47filing
26 May 2026filed 27 May 2026CNTN Canton Strategic HoldingsDigital Asset TreasuriesSEC FORM 4 Sold$43K12,500 at $3.47filing
22 May 2026filed 27 May 2026CNTN Canton Strategic HoldingsDigital Asset TreasuriesSEC FORM 4 Sold$35K10,000 at $3.45filing
22 May 2026filed 27 May 2026CNTN Canton Strategic HoldingsDigital Asset TreasuriesSEC FORM 4 Sold$35K10,000 at $3.45filing
22 May 2026filed 27 May 2026CNTN Canton Strategic HoldingsDigital Asset TreasuriesSEC FORM 4 Sold$51K15,000 at $3.40filing
22 May 2026filed 27 May 2026CNTN Canton Strategic HoldingsDigital Asset TreasuriesSEC FORM 4 Sold$51K15,000 at $3.41filing
22 May 2026filed 27 May 2026CNTN Canton Strategic HoldingsDigital Asset TreasuriesSEC FORM 4 Sold$51K15,000 at $3.41filing
22 May 2026filed 27 May 2026CNTN Canton Strategic HoldingsDigital Asset TreasuriesSEC FORM 4 Sold$34K10,000 at $3.40filing
22 May 2026filed 27 May 2026CNTN Canton Strategic HoldingsDigital Asset TreasuriesSEC FORM 4 Sold$44K12,851 at $3.44filing
22 May 2026filed 27 May 2026CNTN Canton Strategic HoldingsDigital Asset TreasuriesSEC FORM 4 Sold$35K10,000 at $3.45filing
22 May 2026filed 27 May 2026CNTN Canton Strategic HoldingsDigital Asset TreasuriesSEC FORM 4 Sold$35K10,000 at $3.45filing
22 May 2026filed 27 May 2026CNTN Canton Strategic HoldingsDigital Asset TreasuriesSEC FORM 4 Sold$51K15,000 at $3.40filing
22 May 2026filed 27 May 2026CNTN Canton Strategic HoldingsDigital Asset TreasuriesSEC FORM 4 Sold$51K15,000 at $3.41filing
22 May 2026filed 27 May 2026CNTN Canton Strategic HoldingsDigital Asset TreasuriesSEC FORM 4 Sold$51K15,000 at $3.41filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Financials19
Digital Assets2
Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Danina FisherDirector · Director at Hepion Pharmaceuticals, filing Form 4 there in the last year
Vincent S. LoPrioreExecutive Chairman · Executive Chairman at Hepion Pharmaceuticals, filing Form 4 there in the last year
Michael J. PurcellDirector · Director at Hepion Pharmaceuticals, filing Form 4 there in the last year
Gary S. Stetz IIDirector · Director at Hepion Pharmaceuticals, filing Form 4 there in the last year
James Gordon LiddyDirector · Director at Hepion Pharmaceuticals, filing Form 4 there in the last year
Jawad ChaudhryChief Financial Officer · Also traded BCBP in the last 90 days
Thomas M. OBrienChief Executive Officer · Also traded BCBP in the last 90 days